Sign inJoin waitlistJoin the waitlist

Sascha Alexander Tuchman

Directs the Multiple Myeloma and Amyloidosis Program

Credentials: · · · ·

History

Present

Duke University Medical Center
Duke University Medical Center
Chief Resident
Georgetown University School of Medicine
2003
Tufts University

Research

Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma
New England Journal of Medicine · 2019 · 537 citations
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage
Blood Cancer Journal · 2021 · 160 citations
Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemia
Journal of Clinical Oncology · 2009 · 80 citations

Cristina Gasparetto
14 papers
Samuel Rubinstein
12 papers
Eben Lichtman
11 papers
Christopher Jensen
10 papers
AP
Anil Potti
8 papers · 1 as a fellow
Tanya Wildes
8 papers
Hyman Muss
7 papers
SG
Shakira Grant
7 papers · 1 as a fellow
Suzanne Lentzsch
7 papers
William Wood
7 papers
Gary Schiller
6 papers
JS
Jatin Shah
6 papers

Clinical trials

Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma
Principal investigator · Suspended · Phase 2
National Cancer Institute (NCI)
2024–2027
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
Principal investigator · Recruiting · Phase 2
UNC Lineberger Comprehensive Cancer Center
2022–2033
Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma
Principal investigator · Active not recruiting · Phase 1
UNC Lineberger Comprehensive Cancer Center
2019–2039
Registry for Adults With Plasma Cell Disorders (PCD's)
Principal investigator · Recruiting
UNC Lineberger Comprehensive Cancer Center
2018–2029